Cargando…

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma

We aim to determine clinical recurrence and progression risk factors of T1G3 bladder cancer (BCa), and to establish recurrence and progression prediction models. 5-year follow-up records of 106 T1G3 BCa patients from January 2012 to December 2016 were analyzed for recurrence and progression. Two-sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Song, Lu, Mengxin, Peng, Tianchen, Wang, Yejinpeng, Liu, Xuefeng, Xiao, Yu, Wang, Xinghuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856570/ https://www.ncbi.nlm.nih.gov/pubmed/31762799 http://dx.doi.org/10.7150/jca.35866

Ejemplares similares

Inhibition of MELK produces potential anti‐tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway
por: Chen, Song, et al.
Publicado: (2019)

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma
por: Chen, Song, et al.
Publicado: (2021)

PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells
por: Cheng, Songtao, et al.
Publicado: (2019)

Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients
por: Lu, Mengxin, et al.
Publicado: (2019)

Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats
por: Luo, Yongwen, et al.
Publicado: (2020)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

BORA regulates cell proliferation and migration in bladder cancer
por: Cheng, Songtao, et al.
Publicado: (2020)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

Recurrence of Urothelial Bladder Carcinoma in the Colon Presenting as Hematochezia
por: El Douaihy, Youssef, et al.
Publicado: (2016)

Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways
por: Deng, Zhao, et al.
Publicado: (2023)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

Protein Profiling of Bladder Urothelial Cell Carcinoma
por: Hu, Jinghai, et al.
Publicado: (2016)

The role of cell adhesion molecules in the progression of bladder urothelial carcinomas
por: Săndulescu, Andrei Ştefan, et al.
Publicado: (2022)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder
por: Jin, Subin, et al.
Publicado: (2017)

The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
por: Wan, Zhengqiang, et al.
Publicado: (2023)

ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis
por: Chen, Liang, et al.
Publicado: (2019)

DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
por: Wang, Yejinpeng, et al.
Publicado: (2023)

CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α
por: Lu, Mengxin, et al.
Publicado: (2018)

Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma
por: Xia, Chang-sheng, et al.
Publicado: (2020)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
por: Mucciardi, Giuseppe, et al.
Publicado: (2014)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence
por: Popov, Hristo, et al.
Publicado: (2023)

Establishing a prediction model for prostate cancer bone metastasis
por: Chen, Song, et al.
Publicado: (2019)

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2015)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ue1sifhv63ouj1d77kjhvt01rn